Clinical trial

Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR)

NCT00405704 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed

Key facts

NCT number NCT00405704
Title Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR)
Official title Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR)
Acronym RIVUR
Lead sponsor National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH
Collaborators University of North Carolina, Chapel Hill
Status Completed
Phase Phase 3
Study type Interventional
Conditions Vesicoureteral Reflux, Urinary Tract Infections
Intervention type Drug
Interventions Trimethoprim-Sulfamethoxazole, Placebo
Enrollment 607
Start date May 1, 2007
Primary completion Jun 1, 2013
Completion May 1, 2014
First posted Nov 30, 2006
Last update posted Apr 21, 2020
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies